Dr. Louis Éric Trudeau

Professor

Build a Statement of Purpose

Generate a tailored SOP for Dr. Louis Éric Trudeau. Improve your application with a focused, well-structured draft.

Biography

Professor Trudeau is a neuropharmacologist and neurobiologist interested in the mechanisms of neuronal communication in the brain, particularly in neurons that produce the neurotransmitter dopamine. Dopaminergic neurons are the target of many medications, such as antipsychotics used in treating schizophrenia and psychostimulants used for attention disorders. Some of these neurons degenerate in Parkinson's disease. His laboratory seeks to understand the functioning of these neurons and the reasons for their degeneration in that disease. He began his training with a bachelor's degree in psychology at Concordia University in Montreal, followed by a master's in neuroscience at the University of Paris, France. He obtained his PhD in neuroscience from the Clinical Research Institute of Montreal, affiliated with the Université de Montréal, and completed a postdoctoral fellowship in the United States before joining the pharmacology department at Université de Montréal in 1997. His laboratory is part of the Research Group on the Central Nervous System, which includes neuroscience laboratories on the Université de Montréal campus.

Research Interests

Experience

Professor

— Present

Université de Montréal • Montréal, QC

Conducting research in neuropharmacology and teaching courses relating to neuroscience.

Requirements for Université de Montréal

Doctorate Program
Requirements
GPA Requirement
Required:3.3
TOEFL
Listening
Required:20
Reading
Required:20
Writing
Required:20
Speaking
Required:20
Total
Required:90
Prerequisites
MSc in Pharmacology or equivalent Research supervisor confirmation
Application Checklist
  • Transcripts
  • Birth certificate
  • Curriculum Vitae
  • Proof of French proficiency (B2/C1)
Specialization Notes

Department of Pharmacology and Physiology - Research intensive with options in Neuropharmacology and Pharmacogenomics.